≡ Risteys
R14

Documentation Changelog GitHub Contact & Feedback

Pulmonary eosinophilia, not elsewhere classified

DOID EFO Endpoint Browser PheWeb

J10_PULMEOS

eosinophilic pneumonia: An inflammatory lung disorder characterized by an increased number of eosinophils in the lungs. The majority of cases are idiopathic, without identifiable cause. In a minority of cases, medications, fungal infections, and environmental triggers have been implicated. It manifests as acute or chronic. Acute eosinophilic pneumonia is a severe and rapidly progressing pneumonia that may lead to respiratory failure requiring mechanical ventilation. Chronic eosinophilic pneumonia follows a slower course and manifests as fever, dyspnea, cough, and weight loss.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519870

1. Apply sex-specific rule

None

519870

2. Check conditions

None

519870

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — J82
  • Hospital discharge: ICD-9 — 5183
  • Hospital discharge: ICD-8 — 51920
  • Cause of death: ICD-10 — J82
  • Cause of death: ICD-9 — 5183
  • Cause of death: ICD-8 — 51920

2 out of 7 registries used, show all original rules.

447

4. Check minimum number of events

None

447

5. Include endpoints

None

447

6. Filter based on genotype QC (FinnGen only)

436

Control definitions (FinnGen only)

Control exclude
J10_INTERSTITIUM

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
J80-J84
Name in latin
Eosinophilia pulmonum non alibi classificata

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 3168 1780 1353
Only index persons 2462 1464 998
Unadjusted period prevalence (%)
Whole population 0.05 0.05 0.04
Only index persons 0.05 0.05 0.04
Median age at first event (years)
Whole population 59.21 58.03 60.60
Only index persons 56.56 55.95 57.46

-FinnGen-

Key figures

All Female Male
Number of individuals 436 244 192
Unadjusted period prevalence (%) 0.09 0.09 0.09
Median age at first event (years) 57.90 54.33 62.44

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
447
Matched controls
4470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
+∞
307.7
393
*
TGC00
NOMESCO Finland
Bronchial lavation
32.7
148.3
100
39
UGC12
NOMESCO Finland
Flexible bronchoscopy
12.2
127.2
155
187
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
15.2
111.7
109
93
J45.1
ICD-10 Finland
Nonallergic asthma
11.3
111.5
139
171
H02AB06
ATC
prednisolone; systemic
14.5
100.7
400
1656
J45.0
ICD-10 Finland
Predominantly allergic asthma
9.5
97.1
139
202
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
7.1
95.6
229
576
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
8.0
90.9
159
289
J45.9
ICD-10 Finland
Asthma, unspecified
6.4
83.4
216
573
J18.9
ICD-10 Finland
Pneumonia, unspecified
6.3
83.0
272
889
R03DC03
ATC
montelukast; oral
5.4
60.0
162
429
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
7.1
55.5
95
163
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
6.0
54.2
114
240
J84.9
ICD-10 Finland
Interstitial pulmonary disease, unspecified
+∞
52.1
49
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
10.7
51.8
60
64
R03AK08
ATC
formoterol and beclometasone; inhalant
8.7
49.8
68
90
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
4.1
47.1
273
1238
J01MA14
ATC
moxifloxacin; systemic
5.4
46.4
108
247
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
9.9
45.9
56
64
5183A
ICD-9 Finland
Other diseases of lung, Pulmonary eosinophilia
+∞
44.5
42
*
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.4
44.2
144
432
J84.8
ICD-10 Finland
Other specified interstitial pulmonary diseases
+∞
43.4
41
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
7.6
43.3
66
99
R03BA02
ATC
budesonide; inhalant
4.1
41.5
159
534
M05BA04
ATC
alendronic acid; oral
5.0
41.3
106
262
L04AX01
ATC
azathioprine; systemic
9.4
41.2
52
62
D72.1
ICD-10 Finland
Eosinophilia
63.8
40.1
46
8
R03AC02
ATC
salbutamol; inhalant
4.0
38.2
333
1885
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
6.7
38.1
66
113
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
9.7
37.8
46
52
J46
ICD-10 Finland
Status asthmaticus
9.6
37.3
46
53
R03BA08
ATC
ciclesonide; inhalant
5.1
36.3
88
206
R03DA04
ATC
theophylline; systemic, rectal
5.8
35.5
71
140
TDM10
NOMESCO Finland
Puncture of maxillary antrum
7.6
34.7
52
76
R03BA01
ATC
beclometasone; inhalant
4.0
34.7
123
386
51920
ICD-8 Finland
Other diseases of respiratory system, Infiltratio pulmonis eosinophilica
+∞
33.8
32
*
R03AC13
ATC
formoterol; inhalant
5.9
33.3
65
125
H02AB04
ATC
methylprednisolone; systemic
3.9
33.0
121
387
49300
ICD-8 Finland
Asthma, bronchiale
9.5
32.4
40
46
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
5.0
32.1
77
178
R03BB04
ATC
tiotropium bromide; inhalant
4.2
32.0
102
295
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
6.0
31.6
60
112
J33.8
ICD-10 Finland
Other polyp of sinus
10.0
31.3
37
40
XG410
NOMESCO Finland
Flow-volume spirometry
7.3
31.2
48
72
J45.8
ICD-10 Finland
Mixed asthma
7.9
30.6
44
61
GD1AA
NOMESCO Finland
Thorax X-ray examination
3.2
30.3
302
1749
J84.1
ICD-10 Finland
Other interstitial pulmonary diseases with fibrosis
323.2
30.2
30
*
R03AK07
ATC
formoterol and budesonide; inhalant
3.2
27.3
142
562
R03BA05
ATC
fluticasone; inhalant
3.3
27.0
132
503
H02AB07
ATC
prednisone; oral
3.5
26.3
113
397
J47
ICD-10 Finland
Bronchiectasis
9.7
25.9
31
34
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
8.4
25.9
35
45
J01FA06
ATC
roxithromycin; oral
2.8
25.8
243
1323
R03AC12
ATC
salmeterol; inhalant
5.3
25.8
56
118
R01AD05
ATC
budesonide; nasal
4.5
25.7
70
178
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
7.0
25.2
40
62
J45
ICD-10 Finland
Asthma
3.9
24.3
82
244
J01MA12
ATC
levofloxacin; systemic
3.1
23.9
135
555
R03AK11
ATC
formoterol and fluticasone; inhalant
7.8
22.3
32
44
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
4.9
21.1
49
109
H02AB09
ATC
hydrocortisone; systemic
7.8
21.0
30
41
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
39.3
21.0
26
7
GD1AD
NOMESCO Finland
Thorax CT examination
4.1
20.1
59
158
A02BC02
ATC
pantoprazole; systemic
3.0
19.8
356
2541
R03AC03
ATC
terbutaline; inhalant
3.2
19.7
94
347
R01AD09
ATC
mometasone; nasal
2.4
19.1
241
1446
R01AD08
ATC
fluticasone; nasal
2.6
19.0
164
826
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
6.6
18.7
31
50
J32.4
ICD-10 Finland
Chronic pansinusitis
16.0
18.7
30
20
UDH02
NOMESCO Finland
Rhinopharyngoscopy
3.8
17.4
58
170
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
5.2
16.9
36
74
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
93.6
16.7
18
*
R96
ICPC
Asthma
3.1
16.3
75
270
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
16.0
264
1729
J31.0
ICD-10 Finland
Chronic rhinitis
3.6
15.9
58
180
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
5.9
14.8
27
48
J01FA15
ATC
telithromycin; oral
3.2
14.8
63
216
M05BA07
ATC
risedronic acid; oral
4.7
14.0
33
74
J01FA10
ATC
azithromycin; systemic
2.2
13.7
271
1863
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.7
13.6
45
131
R06AE07
ATC
cetirizine; oral
2.1
13.1
209
1317
M81.4
ICD-10 Finland
Drug-induced osteoporosis
29.4
13.0
17
6
WW200
NOMESCO Finland
Immunization
5.8
13.0
24
43
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
13.0
129
674
R06.0
ICD-10 Finland
Dyspnoea
2.2
12.8
161
925
DHB20
NOMESCO Finland
Polypectomy of internal nose
10.1
12.4
24
25
R81
ICPC
Pneumonia
4.2
12.0
33
84
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
4.5
11.9
30
71
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
19.6
11.7
17
9
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.0
11.5
53
190
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.2
11.4
115
601
XG474
NOMESCO Finland
Exhalation nntrogen oxide
4.8
11.3
26
57
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.1
11.0
125
684
J01FA09
ATC
clarithromycin; systemic
2.0
10.9
157
940
R06.2
ICD-10 Finland
Wheezing
3.7
10.8
35
100
Z3231
NOMESCO Finland
Registered nurse
2.1
10.8
148
869
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
18.4
10.8
16
9
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
10.7
98
492
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
3.2
10.6
45
153
M05BB03
ATC
alendronic acid and colecalciferol; oral
5.0
10.6
23
48
DPA30
NOMESCO Finland
Sphenotomy
14.7
10.6
17
12
R03DX09
ATC
mepolizumab; parenteral
+∞
10.5
10
*
R01AD12
ATC
fluticasone furoate; nasal
2.0
10.4
142
830
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
33.4
10.4
13
*
R05
ICD-10 Finland
Cough
2.1
10.3
115
623
R03DC01
ATC
zafirlukast; oral
7.8
10.3
23
31
R06AX27
ATC
desloratadine; oral
2.1
10.1
129
735
R01AD01
ATC
beclometasone; nasal
2.3
10.1
86
418
R02
ICPC
Shortness of breath/dyspnoea
2.3
9.9
83
400
XQ800
NOMESCO Finland
Prick test
3.1
9.7
43
150
J01AA02
ATC
doxycycline; systemic
2.2
9.7
368
3022
L04AA06
ATC
mycophenolic acid; systemic
8.7
9.7
20
24
297, ,
Kela drug reimbursment
+∞
9.4
9
*
J01MA02
ATC
ciprofloxacin; systemic
1.9
9.3
198
1337
J01CA04
ATC
amoxicillin; systemic
2.2
9.3
365
3006
R03BB01
ATC
ipratropium bromide; inhalant
3.3
9.2
36
117
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
19.1
9.0
13
7
4859X
ICD-9 Finland
Bronchopneumonia, organism unspecified[PNEUMONIA NUD]
7.1
8.9
21
31
R01BA52
ATC
pseudoephedrine, combinations; oral
1.9
8.9
147
910
1240
FHL
Bronchoscopy
8.2
8.9
19
24
202
Kela drug reimbursment
Connective tissue diseases, rheumatoid arthritis and comparable disease
2.5
8.9
62
274
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.1
8.9
103
563
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
14.4
8.7
14
10
A02BC01
ATC
omeprazole; systemic
1.9
8.5
145
905
3028
Kela drug reimbursment
Mepolizumab
91.7
8.4
9
*
P01BA02
ATC
hydroxychloroquine; oral
2.6
8.1
49
202
M81.9
ICD-10 Finland
Osteoporosis, unspecified
3.1
8.1
34
115
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.2
8.1
72
355
A07AA02
ATC
nystatin; oral
2.8
7.8
39
146
3027
Kela drug reimbursment
Benralizumab
45.8
7.7
9
*
R03DX10
ATC
benralizumab; systemic
45.8
7.7
9
*
251, ,
Kela drug reimbursment
45.8
7.7
9
*
J96.1
ICD-10 Finland
Chronic respiratory failure
4.6
7.7
18
40
J02AC03
ATC
voriconazole; systemic
25.5
7.6
10
*
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
10.3
7.6
14
14
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
3.3
7.5
29
93
Z3226
NOMESCO Finland
Physiotherapist
2.0
7.5
95
535
R01AD58
ATC
fluticasone, combinations; nasal
1.9
7.5
107
628
R06AX26
ATC
fexofenadine; oral
2.8
7.4
37
139
127
Kela drug reimbursment
Transplant complication
9.6
7.3
14
15
J84.0
ICD-10 Finland
Alveolar and parietoalveolar conditions
+∞
7.3
7
*
ZXA10
NOMESCO Finland
Bilateral
1.9
7.2
100
580
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
2.9
7.2
35
129
ZX120
NOMESCO Finland
Intravenous
2.3
7.1
57
268
J01DA06
ATC
[U] cefuroxime
2.1
7.0
77
411
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
7.7
7.0
15
20
A01AB04
ATC
amphotericin B; local oral
2.8
6.9
34
126
ZXE00
NOMESCO Finland
One hour or less
1.7
6.8
172
1192
E0000UV, ,
ATC
1.7
6.8
190
1353
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
9.5
6.8
13
14
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
9.5
6.8
13
14
B44.1
ICD-10 Finland
Other pulmonary aspergillosis
40.7
6.8
8
*
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
17.0
6.8
10
6
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
6.6
6.7
16
25
R04.2
ICD-10 Finland
Haemoptysis
3.5
6.6
23
69
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
10.2
6.6
12
12
Z2221
NOMESCO Finland
Medical doctor
1.8
6.5
126
808
M05BX04
ATC
denosumab; parenteral
2.6
6.5
39
161
Z94.2
ICD-10 Finland
Lung transplant status
70.8
6.4
7
*
WZC30
NOMESCO Finland
Teaching
1.9
6.4
84
478
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.0
6.3
80
448
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.0
6.3
27
93
A02BC05
ATC
esomeprazole; systemic
1.7
6.3
190
1377
J20
ICD-10 Finland
Acute bronchitis
2.2
6.3
56
276
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
27.1
6.2
8
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.2
69
369
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
6.4
6.2
15
24
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
6.1
79
446
R50.9
ICD-10 Finland
Fever, unspecified
2.0
6.1
77
431
5BA08, ,
NOMESCO Finland
12.7
6.1
10
8
WX872
NOMESCO Finland
Intensive care
2.8
6.1
30
112
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.6
6.0
195
1432
L04AD01
ATC
ciclosporin; systemic
6.2
6.0
15
25

TimeCodeWAS

↥

TODO / Current known limitations:

  • Only showing the top 500 codes, because showing all (sometimes 20k) makes the page too slow.
  • Legend / how to read the glyphs.
  • Proper column names.
  • Show details (e.g. Fisher or Chi-square test, N cases and N controls) when clicking on a row.
  • Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
  • Download CSV not working.
  • No filters and sorters.
  • Limited amount of endpoints with TimeCodeWAS data.
  • Cross-links to Risteys lab test pages for lab test codes.
OMOP Concept
ln(OR) -5y
ln(OR) -1y
ln(OR) -1m
ln(OR) d0
ln(OR) +1m
ln(OR) +1y
ln(OR) +5y
MCC -5y
MCC -1y
MCC -1m
MCC d0
MCC +1m
MCC +1y
MCC +5y
Interstitial pulmonary disease, unspecified
J84.9 (45543277)
Eosinophil count above reference range
386789004 (4304002)
Pulmonary eosinophilia, not elsewhere classified
J82 (45548123)
Other specified interstitial pulmonary diseases
J84.8 (45548126)
Other diseases of lung, Pulmonary eosinophilia
5183A (2000404063)
Bronchial lavation
TGC00 (2001303585)
Neutrophil cytoplasmic Ab [Units/volume] in Serum
5128-4 (3001334)
Proteinase 3 Ab [Units/volume] in Serum
6968-2 (3009445)
Myeloperoxidase IgG Ab [Units/volume] in Serum
48404-8 (3049804)
Body height measure
50373000 (4177340)
Body mass index
60621009 (4245997)
Other interstitial pulmonary diseases with fibrosis
J84.1 (45557630)
Flexible bronchoscopy
UGC12 (2001303610)
SMOKING - SMOKE2: no - SMOKE3: never - SMOKE5: Unspecified
SMOKING-2-3-0 (2002330113)
Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
29257-3 (3002482)
Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
14278-6 (3003284)
Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
14277-8 (3004383)
Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
23826-1 (3012477)
Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
13956-8 (3014162)
Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
21363-7 (3020565)
Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
34645-2 (3031478)
Glomerular basement membrane Ab [Units/volume] in Serum
49774-3 (3032700)
Polyarteritis with lung involvement [Churg-Strauss]
M30.1 (45548401)
Abnormal findings on diagnostic imaging of lung
R91 (45548995)
Predominantly allergic asthma
J45.0 (45557624)
Other diseases of respiratory system, Infiltratio pulmonis eosinophilica
51920 (2000302925)
High resolution CT examination of lungs
GD1DD (2001303632)
Medical doctor
Z2221 (2001311556)
salbutamol; inhalant
R03AC02 (21603256)
Emergency Room and Inpatient Visit
ERIP (262)
Monocytes [#/volume] in Blood
26484-6 (3001604)
Lymphocytes/Leukocytes in Blood
26478-8 (3002030)
IgE [Units/volume] in Serum or Plasma
19113-0 (3005322)
Mycobacterium sp identified in Specimen by Organism specific culture
543-9 (3005702)
Basophils [#/volume] in Blood
26444-0 (3006315)
Eosinophils/Leukocytes in Blood
26450-7 (3006504)
FEV1/FVC
19926-5 (3011505)
Eosinophils [#/volume] in Blood
26449-9 (3013115)
Glucose [Moles/volume] in Serum or Plasma
14749-6 (3013826)
Neutrophils/Leukocytes in Blood
26511-6 (3018010)
Monocytes/Leukocytes in Blood
26485-3 (3019069)
Lymphocytes [#/volume] in Blood
26474-7 (3019198)
Forced vital capacity [Volume] Respiratory system
19870-5 (3020158)
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 (3021347)
Basophils/Leukocytes in Blood
30180-4 (3022096)
Bacteria identified in Blood by Culture
600-7 (3023368)
FEV1
20150-9 (3024653)
Nuclear Ab [Titer] in Serum
29953-7 (3037522)
Bacteria identified in Isolate by Culture
43409-2 (3042936)
Internal Medicine
11 (38004456)
Emergency Medicine
93 (38004510)
CBC W Ordered Manual Differential panel - Blood
57782-5 (40760892)
Differential panel, method unspecified - Blood
69738-3 (42870588)
Bacterial pneumonia, unspecified
J15.9 (45557621)
Polyp of nasal cavity
J33.0 (45562447)
Asthma, unspecified
J45.9 (45562456)
Inpatient Visit
IP (9201)
Pulmonary Disease
29 (38004472)
prednisolone; oral, parenteral
H02AB06 (21602734)
prednisolone
A07EA01 (21600653)
Inpatient Hospital
21 (8717)
Thorax X-ray examination
GD1AA (2001303617)
Outpatient Visit
OP (9202)
Nonallergic asthma
J45.1 (45557625)
montelukast; oral
R03DC03 (21603356)
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 (3001668)
FEV1 --post bronchodilation
20155-8 (3023550)
FEV1/FVC --post bronchodilation
69970-2 (42868459)
FVC percent change Respiratory system
69982-7 (42868471)
FEV1 percent change
69983-5 (42868472)
salmeterol and fluticasone
R03AK06 (21603280)
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 (3020460)
budesonide; inhalant
R03BA02 (21603285)
Supplier / Service Provider
OMOP5117446 (33004)
Office Visit
OMOP4822458 (581477)
Neutrophils [#/volume] in Blood by Automated count
751-8 (3013650)
pantoprazole; oral, parenteral
A02BC02 (21600097)
methylprednisolone; oral, parenteral
H02AB04 (21602732)
fluticasone; inhalant
R03BA05 (21603288)
fluticasone furoate
R03BA09 (45893496)
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 (3002385)
Chronic maxillary sinusitis
J32.0 (45586667)
Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method
4537-7 (3013707)
doxycycline; oral, parenteral
J01AA02 (21602800)
formoterol and beclometasone
R03AK08 (43534839)
roxithromycin; oral
J01FA06 (21602974)
Short blood count panel - Blood
55429-5 (40758558)
Normoblasts [#/volume] in Blood
715-3 (3021589)
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X (38003841)
fluticasone; nasal
R01AD08 (21605050)
fluticasone furoate; nasal
R01AD12 (21605053)
terbutaline; inhalant
R03AC03 (21603257)
Chronic asthma and similar chronic obstructive pulmonary diseases
203 (2001600201)
tiotropium bromide; inhalant
R03BB04 (21603296)
alendronic acid; oral
M05BA04 (21604152)
mometasone; nasal
R01AD09 (21605051)
Spirometry for bronchospasm with prolonged evaluation after bronchodilator
113016006 (4010399)
Emergency Room Visit
ER (9203)
MCH [Entitic mass]
28539-5 (3035941)
Platelets [#/volume] in Blood
26515-7 (3007461)
Erythrocytes [#/volume] in Blood
26453-1 (3026361)
Leukocytes [#/volume] in Blood
26464-8 (3010813)
MCV [Entitic mean volume] in Red Blood Cells
30428-7 (3024731)
Hemoglobin [Mass/volume] in Blood
718-7 (3000963)
Pharmacy visit
OMOP4822462 (581458)
Sodium [Moles/volume] in Serum or Plasma
2951-2 (3019550)
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 (3009542)
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 (3003338)
Potassium [Moles/volume] in Serum or Plasma
2823-3 (3023103)
Pneumonia, unspecified
J18.9 (45601123)
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 (40764999)
calcium (different salts in combination); oral
A12AA20 (21600872)
Outpatient Hospital
22 (8756)
Creatinine [Moles/volume] in Serum or Plasma
14682-9 (3020564)
Otolaryngology
4 (38004449)
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 (3006140)
Urinalysis microscopic panel [#/volume] - Urine by Automated count
50554-5 (3029287)
ciclesonide; inhalant
R03BA08 (21603291)
ciclesonide; nasal
R01AD13 (43534836)
prednisone
A07EA03 (21600655)
prednisone; oral
H02AB07 (21602735)
Leukocytes [#/volume] in Urine
30405-5 (3018095)
CBC panel - Blood by Automated count
58410-2 (40761511)
amoxicillin and beta-lactamase inhibitor; oral, parenteral
J01CR02 (21602863)
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 (3016431)
Asthma
J45 (45596282)
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 (3035995)
amoxicillin; oral, parenteral
J01CA04 (21602823)
Laboratory Visit
OMOP4822461 (32036)
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 (3006923)
moxifloxacin; oral, parenteral
J01MA14 (21603021)
General Practice
1 (38004446)
Acute bronchitis, unspecified
J20.9 (45562445)
erdosteine; oral
R05CB15 (21603394)
Other specified special examinations
Z01.8 (45581003)
Urinalysis macro (dipstick) panel - Urine
24357-6 (3037467)
Other polyp of sinus
J33.8 (45591556)
cetirizine; oral
R06AE07 (21603497)
cefalexin; oral
J01DB01 (21602870)
Case Management Agency
251B00000X (38004193)
Spirometry
127783003 (4133840)
azithromycin; oral, parenteral
J01FA10 (21602978)
clarithromycin; oral, parenteral
J01FA09 (21602977)
Cough
R05 (45606792)
azathioprine; oral, parenteral
L04AX01 (21603927)
Measurement of bone density from two or more locations with X-ray
NK6QA (2001308500)

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
114
116
12.85
104.18
1.6
1.2
—
—
—
0
0
142
240
8.21
86.42
2.7
1.3
357.47
292.35
u/ml
0.26
135
222
51
25
22.90
68.07
1.9
1.2
4.41
0.13
u/ml
1.18
39
11
57
55
11.73
52.79
2.1
1.9
1.83
0.85
g/l
1.31
45
48
50
55
10.11
42.06
3.0
2.4
—
—
—
0
0
38
29
14.23
40.45
1.7
1.4
3.26
2.89
g/l
0.43
29
24
38
29
14.23
40.45
1.7
1.4
6.26
6.39
g/l
0.07
30
24
38
29
14.23
40.45
1.7
1.4
0.33
0.39
g/l
0.31
30
24
261
1276
3.51
37.49
12.5
5.7
—
—
—
0
0
345
2052
3.99
35.47
15.7
5.9
0.33
0.19
e9/l
18.00
329
1782
337
1978
3.86
35.27
14.5
5.8
0.66
0.58
e9/l
7.11
317
1685
36
32
12.15
34.87
1.8
1.3
—
—
—
0
0
337
1992
3.81
34.56
14.4
5.8
0.05
0.04
e9/l
5.88
317
1702
338
2014
3.78
33.95
14.6
5.8
1.86
1.92
e9/l
0.34
320
1772
316
1827
3.49
32.83
14.7
5.8
0.76
0.67
%
2.80
311
1699
135
488
3.53
30.45
1.4
1.3
613.33
554.53
titre
0.13
24
117
345
2198
3.50
28.63
16.6
9.5
4.92
4.06
e9/l
5.80
325
1907
96
350
3.22
20.65
2.6
1.5
—
—
—
0
0
57
153
4.12
19.36
1.7
1.7
14.39
8.67
iu/ml
—
9
40
100
390
3.01
19.05
2.6
2.0
311.11
382.68
nmol/l
0.96
95
357
133
606
2.70
18.91
2.8
2.0
—
—
—
0
0
116
499
2.79
18.39
2.3
1.5
—
—
—
0
0
113
488
2.76
17.72
1.7
1.7
—
—
—
0
0
31
53
6.21
17.68
1.9
1.4
—
—
—
0
0
31
53
6.21
17.68
1.9
1.4
—
—
—
0
0
31
53
6.21
17.68
1.9
1.4
—
—
—
0
0
31
53
6.21
17.68
1.9
1.4
—
—
—
0
0
91
354
2.97
17.30
6.8
4.4
0.71
0.99
%
0.74
41
111
87
331
3.02
17.20
6.3
4.3
0.54
0.62
%
0.19
37
96
87
334
2.99
16.91
6.9
4.5
0.06
0.16
%
0.72
36
90
263
1713
2.30
16.29
19.0
11.7
0.00
0.00
e9/l
0.17
233
1399
208
1259
2.22
15.04
5.3
4.0
7.40
7.40
ph
0.22
156
906
85
349
2.77
14.47
7.4
4.7
0.00
0.17
%
0.98
32
88
259
1756
2.13
13.52
3.3
2.5
82.76
79.09
nmol/l
1.15
246
1558
195
1191
2.13
13.37
5.4
4.3
—
—
—
0
0
27
54
5.26
13.06
2.6
3.1
—
—
—
0
0
44
133
3.56
12.54
1.3
1.2
0.35
0.19
u/ml
—
6
10
146
843
2.09
11.22
11.5
4.9
—
—
—
0
0
296
2193
2.04
11.19
7.3
6.4
10.53
11.39
umol/l
1.25
289
2087
282
2077
1.97
10.55
9.6
6.8
1.21
1.21
mmol/l
0.14
258
1802
34
98
3.67
10.38
1.9
2.1
124.63
127.36
g/l
0.22
24
81
261
1881
1.93
10.33
8.0
6.2
1.21
1.21
mmol/l
0.01
252
1720
91
455
2.26
9.96
2.4
1.6
—
—
—
0
0
135
803
1.98
9.29
3.2
3.1
492.58
527.42
mosm/kgh2o
1.45
125
708
20
42
4.94
9.15
1.3
1.2
—
—
—
0
0
16
14
11.80
9.13
3.5
1.4
39.25
71.74
ug/l
1.27
16
14
29
82
3.71
9.10
6.3
3.1
56.83
59.16
%
0.34
29
82
77
372
2.29
9.10
1.4
1.5
—
—
—
0
0
129
761
1.98
9.06
1.7
1.4
2.43
2.50
g/l
0.16
93
426
86
441
2.18
8.78
1.4
1.5
—
—
—
0
0
22
52
4.40
8.76
1.2
1.1
0.47
1.19
u/ml
0.92
13
26
361
2986
2.09
8.66
13.0
8.2
76.72
80.60
u/l
1.24
351
2819
179
1192
1.84
8.59
9.9
6.2
—
—
—
0
0
54
232
2.51
8.25
1.3
1.4
—
—
—
0
0
162
1074
1.80
7.72
4.1
3.2
—
0.00
estimate
—
0
6
68
334
2.22
7.68
3.4
3.3
224.71
216.92
ng/l
0.04
62
308
92
508
2.02
7.67
6.4
7.8
7.42
7.42
ph
0.15
61
304
119
718
1.90
7.66
3.3
2.4
13.15
12.54
umol/l
0.30
112
662
161
1072
1.78
7.52
2.9
2.2
2.88
3.01
mg/l
0.31
143
920
139
892
1.81
7.31
2.0
1.6
1.38
1.29
mg/l
0.13
113
717
88
487
2.00
7.27
3.5
3.1
4.96
4.84
e9/l
0.08
76
421
93
526
1.97
7.22
7.8
5.0
1.03
1.03
mmol/l
0.05
88
480
167
1139
1.74
7.09
4.2
3.3
0.30
0.43
e6/l
0.58
133
833
108
647
1.88
7.05
1.4
1.3
10.50
11.41
u/ml
0.06
36
253
297
2374
1.75
7.05
6.2
5.0
6.69
6.72
mmol/l
0.10
288
2261
131
835
1.80
7.01
4.6
4.2
186.92
298.09
ng/l
0.58
110
689
110
665
1.87
6.97
3.2
2.4
2.27
2.28
g/l
0.10
104
610
14
17
8.46
6.87
1.0
1.1
—
—
—
0
0
57
273
2.25
6.83
4.4
2.6
7.42
7.42
ph
0.31
50
223
188
1336
1.70
6.82
4.3
3.5
145.31
113.89
e6/l
0.12
156
1031
88
498
1.96
6.80
6.5
7.8
1.55
1.02
mmol/l
0.51
75
423
140
929
1.74
6.44
3.2
2.7
4.06
5.11
e6/l
0.62
132
857
103
625
1.84
6.41
3.3
2.3
23.14
21.92
%
0.38
97
583
204
1507
1.65
6.23
5.3
4.1
281.92
88.58
e6/l
0.41
161
1072
113
712
1.79
6.19
1.5
1.3
22.80
32.77
iu/ml
0.74
35
227
18
49
3.79
5.98
1.2
1.0
0.54
2.10
u/ml
—
10
22
180
1307
1.63
5.77
4.0
3.3
28.62
32.12
u/l
1.55
172
1234
16
41
4.01
5.76
1.2
1.0
0.29
0.35
u/ml
0.09
11
20
235
1825
1.61
5.69
7.4
4.7
33.83
35.38
g/l
4.07
227
1712
16
32
5.15
5.61
1.1
1.0
0.79
0.92
u/ml
0.09
11
11
59
310
2.04
5.58
4.0
3.5
88.05
81.91
ng/l
0.23
50
270
10
10
10.20
5.55
1.5
1.1
—
—
—
0
0
11
14
8.02
5.37
1.5
1.1
—
—
—
0
0
10
11
9.27
5.31
2.1
1.4
—
—
—
0
0
186
1383
1.59
5.29
4.7
3.3
1525.27
1387.38
ng/l
0.21
173
1190
57
303
2.01
5.22
1.3
2.4
—
—
—
0
0
223
1735
1.57
5.19
3.8
2.9
124.79
130.68
ug/l
0.17
205
1601
8
6
13.54
5.09
1.4
1.3
—
—
—
0
0
16
45
3.65
5.09
1.3
1.0
0.40
1.30
u/ml
—
10
15
100
648
1.70
4.87
3.6
3.2
0.73
2.24
e6/l
3.24
55
309
189
1439
1.54
4.71
4.9
3.4
2.34
2.35
mmol/l
1.31
179
1302
23
86
2.77
4.66
4.2
3.4
—
—
—
0
0
39
190
2.15
4.50
4.8
2.6
—
—
—
0
0
42
213
2.07
4.38
2.4
2.4
—
—
—
0
0
15
38
4.05
4.34
1.2
1.3
—
—
—
0
0
23
91
2.61
4.20
1.2
1.2
—
—
—
0
0
100
675
1.62
4.11
5.0
3.2
0.82
0.81
mmol/l
0.20
95
634
59
346
1.81
4.04
5.9
7.3
—
—
—
0
0
80
513
1.68
4.01
3.3
2.6
1.73
1.79
%
0.25
74
456
20
77
2.67
3.86
4.7
4.0
4.29
2.85
mmol/l
0.70
14
50
11
24
4.67
3.76
1.6
1.7
39.82
38.32
%
0.12
11
24
167
1290
1.47
3.66
2.7
2.1
137.36
220.40
u/l
1.91
162
1224
206
1657
1.45
3.66
4.2
3.7
6.45
6.22
ph
1.75
108
929
240
1987
1.45
3.65
19.4
14.7
1.28
1.26
inr
0.21
213
1662
12
30
4.08
3.62
1.1
1.1
—
—
—
0
0
36
188
2.00
3.50
1.3
1.2
—
—
—
0
0
11
27
4.15
3.41
1.1
1.1
—
—
—
0
0
191
1531
1.43
3.38
2.4
2.2
—
—
—
0
0
7
10
7.09
3.37
1.1
1.2
—
—
—
0
0
36
191
1.96
3.35
1.6
1.8
1.66
1.44
g/l
0.54
30
170
68
438
1.65
3.35
5.7
3.2
7.39
7.38
ph
0.29
45
247
14
48
2.98
3.33
1.2
1.1
2.14
4.11
u/ml
—
7
19
65
416
1.66
3.28
5.6
3.1
3.12
2.14
mmol/l
0.93
58
355
6
7
8.67
3.27
1.2
1.1
—
—
—
0
0
9
19
4.81
3.25
1.4
3.0
521.11
742.95
u/ml
—
9
19
48
283
1.78
3.25
1.3
1.2
—
—
—
0
0
69
451
1.63
3.21
1.6
1.3
—
—
—
0
0
35
188
1.93
3.16
1.2
1.2
—
—
—
0
0
295
2579
1.42
3.08
6.3
4.9
1968.20
1266.96
e6/l
—
5
48
30
155
2.00
3.02
2.6
2.0
149.67
304.28
ug/l
1.58
30
147
61
393
1.64
3.01
2.8
2.3
0.21
0.21
g/l
0.17
56
363
16
63
2.60
2.99
1.0
1.1
—
—
—
0
0
159
1256
1.41
2.97
1.7
1.7
21.10
20.79
nmol/l
0.10
139
1039
11
32
3.50
2.92
1.7
4.2
15.72
16.06
%
0.13
11
32
79
547
1.54
2.88
1.3
1.3
—
—
—
0
0
8
18
4.50
2.80
1.1
1.0
—
—
—
0
0
163
1304
1.39
2.80
3.8
3.4
—
—
—
0
0
133
1034
1.41
2.68
4.1
2.7
352.02
348.76
umol/l
0.13
123
904
11
35
3.20
2.66
1.1
1.1
—
—
—
0
0
59
391
1.59
2.61
3.0
2.6
73.47
66.85
e9/l
0.63
44
290
9
25
3.65
2.58
1.1
1.2
—
—
—
0
0
391
3663
1.54
2.38
33.2
17.0
23.37
25.20
mg/l
0.60
373
3060
5
8
6.30
2.37
3.2
3.5
—
—
—
0
0
10
33
3.08
2.37
1.2
1.1
—
—
—
0
0
7
17
4.17
2.37
1.0
1.1
—
—
—
0
0
45
288
1.63
2.30
4.6
4.3
—
—
—
0
0
111
858
1.39
2.28
1.5
1.3
0.56
1.40
u/ml
2.06
25
231
10
35
2.90
2.22
1.2
4.0
7.25
8.76
mmol/l
—
10
35
5
9
5.60
2.22
2.0
1.6
0.69
0.62
mmol/l
—
5
9
242
2113
1.32
2.19
5.2
4.1
0.00
0.01
estimate
0.50
57
420
64
451
1.49
2.16
3.1
2.3
97.47
135.48
ug/g
0.77
52
348
6
14
4.33
2.15
1.2
1.1
—
—
—
0
0
11
42
2.66
2.15
1.0
1.2
—
—
—
0
0
238
2079
1.31
2.12
5.1
4.1
0.00
0.00
estimate
-0.00
58
440
240
2103
1.30
2.07
5.2
4.1
0.00
7.70
estimate
0.80
60
455
13
56
2.36
2.06
2.8
2.1
31.00
32.75
pg
0.69
13
56
7
21
3.37
1.97
1.0
1.0
—
—
—
0
0
11
45
2.48
1.94
1.3
1.3
—
—
—
0
0
15
72
2.12
1.88
1.0
1.1
—
—
—
0
0
9
34
2.68
1.87
1.1
1.2
101.67
105.62
pmol/l
—
9
34
9
34
2.68
1.87
2.7
2.0
—
—
—
0
0
156
1305
1.30
1.86
2.9
2.6
57.64
65.30
u/l
0.61
151
1210
210
1826
1.28
1.86
2.4
2.2
96.98
96.35
pmol/l
0.07
108
921
52
371
1.45
1.68
2.8
2.5
25.25
37.00
u/l
2.00
44
303
63
467
1.41
1.66
2.4
2.8
5.62
8.37
umol/l
1.76
58
418
49
347
1.46
1.64
1.4
1.4
—
—
—
0
0
10
42
2.41
1.62
2.0
1.8
89.02
90.44
%
—
10
42
7
27
2.62
1.52
1.0
1.2
—
—
—
0
0
11
51
2.19
1.51
1.1
1.5
—
—
—
0
0
107
874
1.29
1.50
3.0
2.9
2.48
2.46
mmol/l
1.50
99
787
190
1664
1.25
1.50
5.2
4.0
28.10
72.02
ng/l
0.75
144
1248
16
87
1.87
1.47
1.3
1.3
—
—
—
0
0
314
2912
1.26
1.46
4.8
4.3
15.20
14.90
pmol/l
1.31
293
2631
22
133
1.69
1.45
1.5
1.4
243.40
294.90
ug/g
—
10
76
24
150
1.63
1.41
1.3
4.1
41.69
97.05
mg/l
0.76
18
128
10
46
2.20
1.41
1.0
1.4
30.05
30.45
ng/l
—
10
46
293
2704
1.24
1.38
5.1
4.4
—
0.38
—
0
8
18
105
1.74
1.35
2.7
3.2
0.78
1.85
index
—
9
61
10
47
2.15
1.34
1.1
1.4
27440.00
31297.37
e6/l
—
5
27
9
43
2.12
1.31
3.1
2.0
0.11
0.65
mmol/l
—
9
43
19
114
1.70
1.30
3.1
2.6
1.56
1.59
mg/l
0.05
19
96
9
45
2.02
1.24
1.1
1.3
—
—
—
0
0
8
37
2.18
1.22
1.4
1.1
—
—
—
0
0
89
732
1.27
1.19
1.9
1.8
1083.59
1205.83
nmol/l
0.89
72
557
23
150
1.56
1.17
1.3
4.1
31.06
46.43
mg/l
0.52
17
129
19
118
1.64
1.16
1.4
1.1
—
—
—
0
0
0
35
0.00
1.15
0.0
1.0
—
304.60
—
0
25
5
20
2.52
1.15
1.2
1.7
—
—
—
0
0
161
1418
1.21
1.14
4.4
3.3
6.53
7.27
mmol/l
1.96
141
1177
12
65
1.87
1.14
1.0
1.2
—
—
—
0
0
11
59
1.89
1.08
1.2
1.6
30.63
32.70
g/l
0.19
11
53
16
250
0.63
1.04
1.0
1.3
—
—
—
0
0
15
91
1.67
1.01
2.9
1.8
3.38
4.69
iu/l
—
8
39
129
1125
1.21
1.00
4.3
3.6
0.23
0.01
estimate
0.57
52
349
13
76
1.73
1.00
1.8
1.4
—
—
—
0
0
360
3444
1.23
0.98
6.1
5.4
1.84
1.99
mu/l
1.61
336
3140
8
42
1.92
0.89
1.1
1.2
—
—
—
0
0
15
95
1.60
0.88
1.2
1.5
—
—
—
0
0
262
2453
1.16
0.84
4.0
3.2
76.13
50.89
u/l
1.19
255
2292
197
1808
1.16
0.82
3.4
2.7
—
—
estimate
—
0
0
118
1327
0.85
0.79
3.6
3.4
—
—
—
0
0
5
100
0.49
0.78
1.0
1.1
1.60
1.55
g/l
—
5
100
335
3481
0.85
0.76
4.7
4.5
1.21
1.28
mmol/l
1.36
313
3175
353
3652
0.84
0.75
5.7
5.4
4.65
4.59
mmol/l
0.45
335
3374
152
1378
1.16
0.74
4.4
3.4
37.35
48.61
mg/l
0.44
98
877
360
3716
0.84
0.73
6.5
6.2
2.62
2.65
mmol/l
0.26
340
3422
10
60
1.68
0.72
4.3
2.8
4.05
4.03
mmol/l
—
10
60
10
60
1.68
0.72
4.3
2.8
105.30
105.53
mmol/l
—
10
60
12
76
1.59
0.72
1.3
1.3
—
—
—
0
0
351
3628
0.85
0.71
5.6
5.3
1.60
1.48
mmol/l
5.30
332
3333
9
59
1.54
0.68
4.7
2.8
1.18
1.19
mmol/l
—
9
59
5
92
0.54
0.67
1.0
1.1
—
0.69
—
0
13
31
243
1.30
0.64
3.1
2.4
0.64
0.61
%
0.24
31
243
15
105
1.44
0.60
5.7
5.1
—
—
—
0
0
12
80
1.51
0.60
1.3
1.4
—
—
—
0
0
171
1584
1.13
0.59
5.2
4.0
0.06
0.03
estimate
0.21
54
361
10
64
1.58
0.59
3.9
2.2
0.88
0.86
%
—
10
42
31
247
1.27
0.58
3.1
2.4
1.13
1.16
%
0.13
31
247
12
81
1.49
0.57
1.3
1.3
—
—
—
0
0
12
81
1.49
0.57
1.3
1.3
—
—
—
0
0
37
304
1.24
0.55
6.7
3.4
—
—
—
0
0
12
82
1.48
0.55
1.3
1.3
—
—
—
0
0
6
98
0.61
0.52
3.7
1.7
52.33
40.77
nmol/l
—
6
92
7
45
1.56
0.49
1.6
2.0
—
—
—
0
0
109
994
1.13
0.48
1.3
1.3
—
—
—
0
0
18
137
1.33
0.48
1.2
3.8
1.40
3.41
ratio
—
10
77
55
479
1.17
0.47
3.0
4.4
128.17
40.15
ug/l
0.31
49
400
128
1184
1.11
0.45
5.1
4.2
0.00
0.01
estimate
0.74
53
410
45
388
1.18
0.43
2.1
2.2
0.00
0.04
estimate
0.49
12
82
363
3544
1.13
0.43
7.4
6.9
40.28
39.89
mmol/mol
0.34
349
3321
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
64
714
0.88
0.40
3.5
3.2
0.68
0.81
ug/l
0.68
47
463
7
102
0.68
0.40
1.3
1.1
0.83
0.91
g/l
—
7
102
0
19
0.00
0.39
0.0
1.2
—
171.98
—
0
19
0
19
0.00
0.39
0.0
1.2
—
183.35
—
0
19
149
1404
1.09
0.36
5.2
4.0
4.81
8.41
mg/mmol
1.51
97
853
114
1222
0.91
0.36
5.4
5.6
1.63
2.51
ug/l
2.08
104
1085
6
44
1.37
0.34
1.5
1.3
—
—
—
0
0
6
45
1.34
0.34
1.8
1.1
—
—
—
0
0
6
45
1.34
0.34
1.8
1.1
—
—
—
0
0
134
1264
1.09
0.32
3.1
2.4
—
—
—
0
0
17
138
1.24
0.31
4.8
2.8
280.00
228.98
mg/l
—
5
44
7
100
0.70
0.31
1.0
1.3
36.23
26.10
iu/l
—
7
86
20
166
1.21
0.30
2.2
2.9
—
—
—
0
0
22
185
1.20
0.29
2.0
1.5
—
—
—
0
0
7
56
1.25
0.29
6.9
6.5
411.14
357.67
umol/l
—
7
49
8
110
0.72
0.29
1.0
1.1
—
—
—
0
0
23
195
1.19
0.29
1.9
2.3
0.00
0.02
estimate
—
6
66
15
121
1.25
0.29
15.4
9.3
—
—
—
0
0
55
505
1.10
0.24
1.6
1.3
—
—
—
0
0
6
84
0.71
0.24
1.8
1.2
32.38
9.70
u/l
—
6
64
5
39
1.29
0.23
1.8
1.7
8.04
10.46
%
—
5
39
18
153
1.18
0.22
2.9
1.5
0.12
0.33
mg/l
—
10
65
5
40
1.25
0.22
1.2
1.0
—
—
—
0
0
357
3620
0.93
0.21
5.5
5.5
5.83
6.03
mmol/l
1.56
334
3311
0
11
0.00
0.21
0.0
1.5
—
7.96
—
0
11
15
126
1.20
0.21
1.3
1.7
—
—
—
0
0
0
12
0.00
0.21
0.0
1.4
—
59.58
—
0
12
39
355
1.11
0.20
2.8
2.5
6.66
7.00
ug/l
0.06
34
314
10
80
1.26
0.20
2.7
2.8
9.87
9.88
pmol/l
—
10
80
6
48
1.25
0.20
1.5
1.4
262.33
272.29
mosm/kgh2o
—
6
34
167
1614
1.06
0.20
2.2
2.0
1.29
1.32
mmol/l
0.17
139
1350
6
52
1.16
0.19
1.3
1.8
—
—
—
0
0
11
91
1.21
0.17
5.4
2.1
24.82
33.04
umol/l
2.03
11
78
42
389
1.09
0.16
5.5
3.6
7.30
7.37
ph
0.67
34
276
141
1456
0.95
0.16
4.2
3.7
—
0.86
—
0
7
90
865
1.05
0.13
1.7
1.8
420.74
451.11
pmol/l
0.57
78
723
13
113
1.15
0.13
1.3
1.4
—
—
—
0
0
377
3740
1.05
0.12
24.2
15.4
—
—
—
0
0
96
928
1.04
0.11
5.7
4.2
1.02
1.02
kg/l
0.56
71
619
5
46
1.09
0.09
2.0
2.3
—
—
—
0
0
19
203
0.93
0.06
2.0
1.9
—
—
—
0
0
23
237
0.97
0.01
1.2
1.2
134.93
137.14
u/ml
0.01
11
92
26
266
0.98
0.00
1.3
1.4
—
—
—
0
0
22
218
1.01
0.00
2.0
3.2
18.18
111.30
u/ml
1.05
22
212
32
322
0.99
0.00
4.3
2.7
6.40
6.09
ph
1.05
24
222
0
9
0.00
0.00
0.0
1.4
—
0.00
—
0
9
0
9
0.00
0.00
0.0
2.2
—
2077.00
—
0
9
5
50
1.00
0.00
1.2
1.1
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
16
160
1.00
-0.00
1.1
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
6
69
0.87
-0.00
1.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
89
1.01
-0.00
3.7
3.0
0.70
0.90
nmol/l
—
9
73
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
6.53
—
0
6

Mortality – FinRegistry

↥

Association

Association between endpoint J10_PULMEOS and mortality.

Females

Parameter HR [95% CI] p-value
J10_PULMEOS 1.613 [1.36, 1.91] < 0.001
Birth year 0.994 [0.99, 1.0] 0.183

During the follow-up period (1.1.1998 — 31.12.2019), 276 out of 1053 females with J10_PULMEOS died.

Males

Parameter HR [95% CI] p-value
J10_PULMEOS 1.865 [1.56, 2.23] < 0.001
Birth year 0.986 [0.98, 1.0] 0.004

During the follow-up period (1.1.1998 — 31.12.2019), 327 out of 857 males with J10_PULMEOS died.

Mortality risk

Mortality risk for people of age

years, who have J10_PULMEOS.

N-year risk Females Males
1 0.16% 0.372%
5 0.928% 2.274%
10 2.312% 5.463%
15 4.365% 9.521%
20 7.696% 15.863%

Relationships between endpoints

↥

Index endpoint: J10_PULMEOS – Pulmonary eosinophilia, not elsewhere classified

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data